General Organization and Business (Details)			3 Months Ended	12 Months Ended
	Feb. 12, 2018 shares	Nov. 10, 2010 shares	Mar. 31, 2021 USD ($) shares	Dec. 31, 2020
General Organization and Business (Details) [Line Items]
Number of shares issued			132,000
Accumulated deficit (in Dollars) | $			$ 42,000,000
Net cash used in operating activities (in Dollars) | $			180,438
Cash on hand (in Dollars) | $			$ 47,000
Related party, description				The Company was advanced $835,000 through the issuance of 10% notes payable to a related party during 2020. The Company was advanced $220,000 through the issuance of 10% notes payable to a related party during the first quarter of 2021. In addition, the Company was advanced $50,000 through the issuance of 10% notes payable to a related party thus far during the second quarter of 2021.
Boston Therapeutics, Inc. [Member] | Agreement and Plan of Merger [Member]
General Organization and Business (Details) [Line Items]
Common stock issued to shareholders		4,000,000
Outstanding common stock		100.00%
CureDM Group Holdings, LLC [Member] | Contribution Agreement [Member]
General Organization and Business (Details) [Line Items]
Number of shares issued	47,741,140
Number of shares issued at time of delivered	25,000,000
Number of shares issued at time of milestone	22,741,140
Number of tranches for delivered | Tranches	4
Number of shares issued per tranche	5,685,285